Winner of the Actuarial Award in UK, 2014
- FR
- EN
Winner of the Actuarial Award in UK, 2014
This paper addresses the problem of finding hedging strategies in an incomplete market.
Cardiovascular diseases are the main cause of mortality in the world and insurers have to take into consideration any significant changes in this field… The arrival of the long-awaited Novel Oral AntiCoagulant drugS o
In early September 2013, SCOR launched its fifth three-year strategic plan called “Optimal Dynamics”, running from mid-2013 to mid-2016.
The rising level of long-term care (LTC) expenditures and their financing sources are likely to impact savings and capital accumulation and henceforth the pattern of growth.
SCOR announces the creation of a local entity in Brazil, SCOR Brasil Resseguros SA (SCOR Brasil Re), following the licence to operate as a Local Reinsurer granted by the Brazilian insurance authority SUSEP on 26 Augus
SCOR's first half of 2014 results.
SCOR delivers a strong performance for the first half 2014 with net income of EUR 256 million, up 35% from H1 2013
SCOR delivers a strong performance for the first half 2014 with net income of EUR 256 million, up 35% from H1 2013
Details about the liquidity account at 30 june 2014 and of the last half-year statement
Lupus is a disease caused by a disorder of the immune system. Its pathophysiological mechanisms, which include genetic, immunological and environmental factors, remain poorly understood. This is a rare disease.
NUEVOS ENFOQUES DEL LED (LUPUS ERITEMATOSO DISEMINADO) El lupus es una patología asociada a un pro blema inmunitario.
Pagination